At CELFULL, we are advancing our leading programs across three key areas: therapeutic agents addressing medical challenges with significant unmet needs, nutraceutical agents designed to counteract aging-related weaknesses and functional degradation in human organs, and skincare agents formulated to maintain a youthful glow at any age. Our unwavering commitment lies in deepening our understanding of the cell biology that controls aging, enabling us to develop interventions for longer, healthier, and more fulfilling lives.
Therapeutical Candidate | Inidication | Development Stage | |||
---|---|---|---|---|---|
Discovery | Pre-Clinical | Phase Ⅰ | Phase Ⅱ | ||
PHE1411 | Phenylketonuria | ||||
CF2108 | Age-related sleep disorders | ||||
CFS2212 | COVID-19 related fatige syndrome | ||||
Nutraceutial Candidate | Area | Development Stage | |||
Discovery | TechDev | Product Dev | Launch | ||
CF1906 | Aging | ||||
CF2010 | Cardiovascular Health | ||||
CF2201 | Antidepression | ||||
CF2202 | Ovary Health | ||||
Skincare Candidate | Area | Development Stage | |||
Discovery | TechDev | Product Dev | Launch | ||
CF2105 | Anti-wrinkle |